Sesen Bio Stock Predictions

Healthcare > Biotechnology

Buy SESN

*Your capital is at risk

$0.629

+0 (+0%)

At Close: Jun 06, 2023

Currently predicting for Mon, 8 Jun 2026

SESN Prediction Chart

SESN Predictions History

Latest community submissions for SESN.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
cbrennem1234abcd.238368	Jul 21, 2021	Bullish	$4.13	X	—	1
JS Pro	Feb 16, 2021	$2.75 -8.94%	$3.02	X	91.06%	0
Simply Simpleton @SimplySimpleton.202784	Feb 16, 2021	Bullish	$3.02	X	—	1
JS Pro	Dec 31, 2020	$1.45 +7.41%	$1.35	X	92.59%	0
Derrick Konier @DerrickKonier.182927	Dec 31, 2020	Bullish	$1.35	X	—	0
JS Pro	Dec 21, 2020	$1.73 +31.06%	$1.32	X	68.94%	1
JS Pro	Dec 18, 2020	$1.68 -3.45%	$1.74	X	96.55%	0
JS Pro	Dec 8, 2020	$1.48 -10.84%	$1.66	X	89.16%	0
JS Pro	Nov 25, 2020	$1.14 -0.87%	$1.15	X	99.13%	2
JS Pro	Nov 19, 2020	$1.23 +6.96%	$1.15	X	93.04%	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for SESN with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT SESEN BIO INC.

Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment of bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer; to treat non-muscl...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
FISV	0%	Nov 30
K KEEL	0%	Nov 30
D DFTX	0%	Nov 30
R RKLZ	0%	Nov 30
R RKTO	0%	Nov 30

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by